Research Article | Open Access
Jo-Ting Tsai, Hui-Ching Liu, Yue-Hwa Chen, "Suppression of Inflammatory Mediators by Cruciferous Vegetable-Derived Indole-3-Carbinol and Phenylethyl Isothiocyanate in Lipopolysaccharide-Activated Macrophages", Mediators of Inflammation, vol. 2010, Article ID 293642, 5 pages, 2010. https://doi.org/10.1155/2010/293642
Suppression of Inflammatory Mediators by Cruciferous Vegetable-Derived Indole-3-Carbinol and Phenylethyl Isothiocyanate in Lipopolysaccharide-Activated Macrophages
This study was aimed to examine the effects of indole-3-carbinol (I3C) and -phenylethyl isothiocyanate (PEITC), bioactive components present in cruciferous vegetable, on the production of inflammatory mediators, including nitric oxide (NO), tumor necrosis factor- (TNF-) and interleukin-10 (IL-10), in lipopolysaccharide- (LPS-) stimulated RAW 264.7 macrophages. Possible mechanisms of the NO-inhibitory effects were also explored. The results indicated that I3C and PEITC inhibited NO production, and this suppression was associated with decreased production of TNF- and IL-10 by activated macrophages. In addition, I3C suppressed NO production even after the inducible nitric oxide synthase (iNOS) protein had been produced, but such an inhibitory effect was not observed in cells treated with PEITC. Furthermore, both compounds reduced the NO contents generated from an NO donor in a cell-free condition, suggesting that the increased NO clearance may have contributed to the NO-inhibitory effects. In summary, both I3C and PEITC possessed antiinflammatory effects by inhibiting the productions of NO, TNF-, and IL-10, although the NO-inhibitory effects may have involved in different mechanisms.
Macrophages play important roles in a host’s immune defense system during infection as well as in the processes of disease development. Activation of macrophages by stimuli, such as the bacterial endotoxin, lipopolysaccharide (LPS), and viruses, increases the production of numerous inflammatory mediators, including nitric oxide (NO), prostaglandin E2 (PGE2), and various cytokines . NO is a small radical molecule that possesses many physiological functions, being involved in vasorelaxation, neurotransmission, immunoregulation, and inflammation. NO is synthesized from the amino acid L-arginine by nitric oxide synthase (NOS) in various cells and tissues. Among isoforms identified, the inducible form of NOS (iNOS) is mainly expressed in macrophages and lymphocytes, and is synthesized by stimulants such as bacterial endotoxin lipopolysaccharide (LPS) and cytokines, including interferon- (IFN-), interleukin-1 (IL-1), and tumor necrosis factor- (TNF-) . Low concentrations of NO produced by iNOS are involved in antipathogenic and antitumor responses of macrophages. However, prolonged overproduction of NO and the dysregulated expressions of cytokines during chronic inflammation have been implicated in several pathological conditions, such as autoimmune diseases and cancers [2–4]. Hence, agents that regulate the production of cytokines and suppress the overproduction of NO may possess protective roles in inflammation-related diseases.
There is increasing interest in using natural products to modulate immune responses and neutralize inflammatory processes because of their fewer side effects and lower cytotoxicities [5, 6]. Cruciferous vegetables, including broccoli, cauliflower, cabbage, and mustard, are reported to play protective roles in different diseases. The high contents of glucosinolates and glucosinolate derivatives, including isothiocyanates and indoles, were implicated as being responsible for the biological effects of these vegetables [7–9]. Both isothiocyanate and indole derivatives, including phenylethyl isothiocyanate (PEITC), sulforaphane, and indole-3-carbinol (I3C), are reported to suppress NO production by inhibiting inducible nitric oxide synthase (iNOS) expression in activated RAW 264.7 macrophages [10–12]. Although sulforaphane and PEITC were shown to decrease TNF- production and interleukin-1 (IL-1) mRNA expression, respectively, in LPS-activated macrophages [10, 11], there is little information on the effects of I3C on cytokine production. Besides, the effects of PEITC or I3C on these inflammatory mediators are usually examined individually, not simultaneously, or compared under the same conditions. Because the productions of NO and cytokines are closely associated, this study attempted to examine and compare the effects of PEITC and I3C on the productions of NO and cytokines, including the proinflammatory TNF-, and the antiinflammatory IL-10, in LPS-activated RAW 264.7 cells. To obtain further insights into the NO-suppressive effects of these compounds, indirect NOS enzyme activities and in vitro NO clearance activities were also investigated. Results from this study may increase our understanding of how compounds from cruciferous vegetable modulate immune functions, and the potential use of these compounds in inflammation-related diseases.
2. Materials and Methods
2.1. Chemicals and Biochemicals
I3C, PEITC, LPS, sulfanilamide, N-(1-naphthyl)ethylenediamine dihydrochloride, and sodium nitrite were commercially obtained from Sigma Chemical (St. Louis, MO). Absolute ethanol was purchased from Merck (Darmstadt, Germany). Dulbecco's modified Eagle medium (DMEM) and fetal bovine serum (FBS) were from GIBCO (Grand Island, NY). All other laboratory chemicals were purchased from Sigma and USB (Cleveland, OH).
2.2. Cell Culture
Murine monocyte-macrophage RAW 264.7 cells were obtained from the Biosource Collection and Research Center, Hsinchu, Taiwan (BCRC 60001). Cells were grown as monolayers in DMEM supplemented with 10% FBS at C in an atmosphere of 95% air and 5% CO2. I3C and PEITC were dissolved in absolute ethanol, and the concentration of absolute ethanol added to the media never exceeded 0.01% (v/v).
2.3. Assays for NO and Cytokine Production and Release
Nitrite concentration in the culture medium was quantified spectrophotometrically after its reaction with the Griess reagent (a 1 : 1 mixture of 1% sulfanilamide/5% H3PO4 and 0.1% naphthylethylenediamine dihydrochloride) . The production and release of cytokines in the culture medium were determined using commercial enzyme-linked immunosorbent assay (ELISA) kits (Amersham Biosciences, Buckinghamshire, UK) following the manufacturers’ instructions.
2.4. In Vitro NO Clearance Activity
NO clearance activities of these compounds were determined according to a method modified from by Marcocci et al. . Basically, I3C and PEITC were incubated in an NO donor solution of sodium nitroprusside (SNP) (10 mM) at room temperature for 30 minutes in a cell-free condition, and the nitrite concentration in the reaction mixture was determined using the Griess reagent.
2.5. Statistical Analysis
Values are expressed as the mean standard deviation (SD), and were analyzed using SAS software versus 6.12 (SAS Institute, Cary, NC). One-way analysis of variance (ANOVA) followed by Fisher’s least significant difference test and Student’s t-test was used to determine statistical differences between groups. The significance of the mean differences was based on a P value of .05.
3. Results and Discussion
3.1. Effects of I3C and PEITC on LPS-Stimulated NO Production
Figure 1 shows that I3C and PEITC inhibited 52% to 77% and 22% to 89% of LPS-stimulated NO production, respectively. Because no cytotoxic effect was observed after cells were treated with LPS in the presence of I3C or PEITC for 24 hours, the NO-inhibitory effects by I3C and PEITC were not due to cytotoxicity. Comparing to the results obtained from macrophages that were activated by LPS/ IFN- , greater NO-inhibitory potencies were observed in LPS-activated macrophages, indicating that IFN- might generate more complicated responses on NO production in macrophages.
Although evidence demonstrated that the decreased NO production by I3C and PEITC is mediated through the suppressing iNOS protein expression in activated macrophages [12, 15], other possibilities may exist. Because the expression of iNOS may be also regulated at the posttranslation level , iNOS enzyme activity was indirectly evaluated. After being activated with LPS for different periods of time, macrophages were treated with I3C or PEITC for up to 24 hours, and the NO content in the culture medium was examined. The results showed that LPS-stimulated NO production was inhibited by I3C treatment regardless of the pre- or cotreatment with LPS, although cotreated cells exhibited a greater extent of inhibition (Figure 2(a)), suggesting that I3C interfered with iNOS’s enzyme activity. PEITC, on the other hand, showed a distinct pattern in LPS-treated cells, where no inhibition was noted in 12-hour LPS-pretreated cells, less inhibition was observed in 6-hour pretreated cells, and the maximal NO suppression occurred in cotreated cells (Figure 2(b)), indicating that PEITC had no impact on iNOS enzyme activity once the protein was synthesized. NO is a small molecule with free radical characteristics, so it readily interacts with other compounds. Because I3C was reported to be capable of acting as a scavenger of free radicals , in vitro NO clearance activity of these compounds was also examined. As shown in Figure 3, both I3C (50 M) and PEITC (5 M) decreased the levels of NO generated from the NO donor. Therefore, I3C and PEITC might directly interact with NO, thus decreasing its availability. Blomhoff  suggested that cruciferous vegetables are dietary plants rich in compounds that can reduce oxidative stress, including reactive nitrogen species (RNS), which may be formed from excess NO free radicals, and I3C was shown to serve as a scavenger of free radicals and inhibit lipid peroxidation [17, 19]. Furthermore, glutathione S-transferase (GST), a phase II xenobiotic metabolism enzyme which can be induced by I3C or PEITC, was indicated to be able to inactivate NO , so I3C and PEITC may also indirectly eliminate NO through the induction of GST. Alternatively, LPS-induced macrophage activation was reported to require the LPS receptor complex, which plays essential roles in binding and in mediating the response to LPS . Therefore, binding interference of I3C or PEITC with either LPS and/or the LPS receptor complex cannot be ruled out. Nevertheless, PEITC did not show any impact on NO production when macrophages were pretreated with LPS for 12 hours (Figure 2(b)). A higher NO concentration generated from the LPS-treated cells (18.31 0.60 M) comparing to the in vitro condition (8.96 0.08 M) may explain the discrepancy, because the NO concentration was too high for PEITC to react without inhibited iNOS activity. On the other hand, the binding of intracellular proteins by PEITC  may also decrease its bioavailability on NO clearance. Taken together, different mechanisms may be involved in the NO-inhibitory effects of I3C and PEITC. I3C may act through decreasing iNOS expression, interfering with iNOS enzyme activity, and directly trapping NO to decrease NO availability, whereas PEITC mainly acts through decreasing iNOS expression and directly interacting with NO. Nevertheless, the molecular mechanisms of NO’s inhibitory effects against these derivatives require further investigation.
3.2. Effects of I3C and PEITC on the Production of Cytokines
The production of NO can be regulated by various cytokines, so the release of the proinflammatory TNF- and the antiinflammatory cytokine, IL-10, was determined. As shown in Figure 4, LPS significantly enhanced the productions of TNF- and IL-10 by RAW 264.7 cells, and high concentrations of I3C and PEITC suppressed such enhancements of both TNF- and IL-10. The expression of iNOS can be induced by proinflammatory cytokines, such as TNF- , and inhibited by antiinflammatory cytokines, including IL-10 . It is reasonable to assume that the NO-inhibitory effects of these compounds may occur through suppressed production of TNF- or through increased production of IL-10. Nonetheless, both TNF- and IL-10 were significantly inhibited by high concentrations of I3C and PEITC in LPS-stimulated macrophages, suggesting that IL-10 might not play a crucial role in I3C- and PEITC-induced NO inhibition. Because NO production may be regulated by a variety of mechanisms as discussed, whereas TNF- and IL-10 inhibition may rely on suppression of gene expression, that is, via NF-B signaling pathway, the inhibitory effects on TNF- and IL-10 production by I3C and PEITC are not as potent as that of NO production. On the other hand, a variety of cytokines can be released after treatment with LPS, and are mutually regulated; hence other cytokines, in addition to TNF- and IL-10, may act additively or synergistically to affect NO production. Furthermore, cytokines not only modulate NO production, but NO may also modulate the secretion of cytokines. NO was shown to modulate the production of IL-2 and IFN- by T cells  as well as TNF- and IL-1 in activated alveolar macrophages , and this may partially explain the effects of I3C and PEITC on the production of cytokines. Finally, different studies indicated that the expression of IL-10 in cultured macrophage might not reflect what is observed in animals [26, 27]. For example, an immunomodulator, SR31747A, downregulates both NO and IL-10 expressions in LPS-activated RAW 264.7 macrophages, but it enhances IL-10 production in a murine model of sepsis . Thus, the results obtained from this study are informative, but require further investigation.
In conclusion, I3C and PEITC possess antiinflammatory effects by inhibiting the productions of NO, TNF-, and IL-10 in LPS-stimulated macrophages. NO’s inhibitory effect on I3C, in addition to decreasing the expression of iNOS, may at least partly be through interfering with iNOS enzyme activity as well as direct NO clearance activity, whereas PEITC may act through its direct NO clearance activity but not interfere with iNOS enzyme activity.
This work was supported by grants from the National Science Council (NSC 90-2320-B-038-039) and Taipei Medical University—Wan-Fang Hospital (94TMU-WFH-216), Taiwan.
- D. M. Mosser and J. P. Edwards, “Exploring the full spectrum of macrophage activation,” Nature Reviews Immunology, vol. 8, no. 12, pp. 958–969, 2008.
- K. L. Davis, E. Martin, I. V. Turko, and F. Murad, “Novel effects of nitric oxide,” Annual Review of Pharmacology and Toxicology, vol. 41, pp. 203–236, 2001.
- L. J. Hofseth, “Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer,” Cancer Letters, vol. 268, no. 1, pp. 10–30, 2008.
- H. Ohshima and H. Bartsch, “Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis,” Mutation Research, vol. 305, no. 2, pp. 253–264, 1994.
- Y.-J. Surh, K.-S. Chun, H.-H. Cha et al., “Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF- activation,” Mutation Research, vol. 480-481, pp. 243–268, 2001.
- G. Hodge, S. Hodge, and P. Han, “Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: potential therapeutic use in the treatment of inflammatory bowel disease,” Cytometry, vol. 48, no. 4, pp. 209–215, 2002.
- G. S. Stoewsand, “Bioactive organosulfur phytochemicals in brassica oleracea vegetables—a review,” Food and Chemical Toxicology, vol. 33, no. 6, pp. 537–543, 1995.
- R. McDanell, A. E. M. McLean, A. B. Hanley, R. K. Heaney, and G. R. Fenwick, “Chemical and biological properties of indole glucosinolates (glucobrassicins): a review,” Food and Chemical Toxicology, vol. 26, no. 1, pp. 59–70, 1988.
- G. R. Fenwick, R. K. Heaney, and W. J. Mullin, “Glucosinolates and their breakdown products in food and food plants,” Critical Reviews in Food Science and Nutrition, vol. 18, no. 2, pp. 123–201, 1983.
- M. Dey, D. Ribnicky, A. G. Kurmukov, and I. Raskin, “In vitro and in vivo anti-inflammatory activity of a seed preparation containing phenethyl isothiocyanate,” Journal of Pharmacology and Experimental Therapeutics, vol. 317, no. 1, pp. 326–333, 2006.
- E. Heiss, C. Herhaus, K. Klimo, H. Bartsch, and C. Gerhäuser, “Nuclear factor B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms,” Journal of Biological Chemistry, vol. 276, no. 34, pp. 32008–32015, 2001.
- Y.-H. Chen, H.-J. Dai, and H.-P. Chang, “Suppression of inducible nitric oxide production by indole and isothiocyanate derivatives from brassica plants in stimulated macrophages,” Planta Medica, vol. 69, no. 8, pp. 696–700, 2003.
- C. Privat, F. Lantoine, F. Bedioui, E. M. van Brussel, J. Devynck, and M.-A. Devynck, “Nitric oxide production by endothelial cells: comparison of three methods of quantification,” Life Sciences, vol. 61, no. 12, pp. 1193–1202, 1997.
- L. Marcocci, J. J. Maguire, M. T. Droylefaix, and L. Packer, “The nitric oxide-scavenging properties of ginkgo biloba extract EGb 761,” Biochemical and Biophysical Research Communications, vol. 201, no. 2, pp. 748–755, 1994.
- P. Rose, Y. K. Won, C. N. Ong, and M. Whiteman, “-phenylethyl and 8-methylsulphinyloctyl isothiocyanates, constituents of watercress, suppress LPS induced production of nitric oxide and prostaglandin E2 in RAW 264.7 macrophages,” Nitric Oxide, vol. 12, no. 4, pp. 237–243, 2005.
- H. Kleinert, A. Pautz, K. Linker, and P. M. Schwarz, “Regulation of the expression of inducible nitric oxide synthase,” European Journal of Pharmacology, vol. 500, no. 1–3, pp. 255–266, 2004.
- M. B. Arnao, J. Sanchez-Bravo, and M. Acosta, “Indole-3-carbinol as a scavenger of free radicals,” Biochemistry and Molecular Biology International, vol. 39, no. 6, pp. 1125–1134, 1996.
- R. Blomhoff, “Dietary antioxidants and cardiovascular disease,” Current Opinion in Lipidology, vol. 16, no. 1, pp. 47–54, 2005.
- H. G. Shertzer, M. P. Niemi, and M. W. Tabor, “Indole-3-carbinol inhibits lipid peroxidation in cell-free systems,” Advances in Experimental Medicine and Biology, vol. 197, pp. 347–356, 1986.
- J. Z. Pedersen, F. De Maria, P. Turella et al., “Glutathione transferases sequester toxic dinitrosyl-iron complexes in cells: a protection mechanism against excess nitric oxide,” Journal of Biological Chemistry, vol. 282, no. 9, pp. 6364–6371, 2007.
- M. Fujihara, M. Muroi, K.-I. Tanamoto, T. Suzuki, H. Azuma, and H. Ikeda, “Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex,” Pharmacology and Therapeutics, vol. 100, no. 2, pp. 171–194, 2003.
- L. Mi and F.-L. Chung, “Binding to protein by isothiocyanates: a potential mechanism for apoptosis induction in human nonsmall lung cancer cells,” Nutrition and Cancer, vol. 60, supplement 1, pp. 12–20, 2008.
- F. Y. Liew, “Interactions between cytokines and nitric oxide,” Advances in Neuroimmunology, vol. 5, no. 2, pp. 201–209, 1995.
- F. Q. Cunha, S. Moncada, and F. Y. Liew, “Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon- in murine macrophages,” Biochemical and Biophysical Research Communications, vol. 182, no. 3, pp. 1155–1159, 1992.
- M. J. Thomassen, L. T. Buhrow, M. J. Connors, F. T. Kaneko, S. C. Erzurum, and M. S. Kavuru, “Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages,” American Journal of Respiratory Cell and Molecular Biology, vol. 17, no. 3, pp. 279–283, 1997.
- S. B. Pruett, R. Fan, Q. Zheng, and C. Schwab, “Differences in IL-10 and IL-12 production patterns and differences in the effects of acute ethanol treatment on macrophages in vivo and in vitro,” Alcohol, vol. 37, no. 1, pp. 1–8, 2005.
- C. J. Gannon, D. L. Malone, and L. M. Napolitano, “Reduction of IL-10 and nitric oxide synthesis by SR31747A (sigma ligand) in RAW murine macrophages,” Surgical Infections, vol. 2, no. 4, pp. 267–273, 2001.
Copyright © 2010 Jo-Ting Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.